USANA HEALTH SCIENCES INC (USNA) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:USNA • US90328M1071

21.43 USD
+0.23 (+1.08%)
At close: Feb 10, 2026
21.43 USD
0 (0%)
After Hours: 2/10/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

USNA gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 36 industry peers in the Personal Care Products industry. While USNA has a great health rating, its profitability is only average at the moment. USNA has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year USNA was profitable.
  • USNA had a positive operating cash flow in the past year.
  • Each year in the past 5 years USNA has been profitable.
  • In the past 5 years USNA always reported a positive cash flow from operatings.
USNA Yearly Net Income VS EBIT VS OCF VS FCFUSNA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

  • USNA has a Return On Assets of 2.34%. This is comparable to the rest of the industry: USNA outperforms 55.56% of its industry peers.
  • USNA has a Return On Equity of 3.22%. This is in the better half of the industry: USNA outperforms 63.89% of its industry peers.
  • USNA has a Return On Invested Capital (4.04%) which is comparable to the rest of the industry.
  • USNA had an Average Return On Invested Capital over the past 3 years of 10.32%. This is in line with the industry average of 11.63%.
  • The last Return On Invested Capital (4.04%) for USNA is well below the 3 year average (10.32%), which needs to be investigated, but indicates that USNA had better years and this may not be a problem.
Industry RankSector Rank
ROA 2.34%
ROE 3.22%
ROIC 4.04%
ROA(3y)9.11%
ROA(5y)13.39%
ROE(3y)12.23%
ROE(5y)18.88%
ROIC(3y)10.32%
ROIC(5y)15.36%
USNA Yearly ROA, ROE, ROICUSNA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

  • With a Profit Margin value of 1.86%, USNA perfoms like the industry average, outperforming 58.33% of the companies in the same industry.
  • USNA's Profit Margin has declined in the last couple of years.
  • USNA's Operating Margin of 4.58% is in line compared to the rest of the industry. USNA outperforms 52.78% of its industry peers.
  • In the last couple of years the Operating Margin of USNA has declined.
  • Looking at the Gross Margin, with a value of 79.18%, USNA belongs to the top of the industry, outperforming 94.44% of the companies in the same industry.
  • USNA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 4.58%
PM (TTM) 1.86%
GM 79.18%
OM growth 3Y-18.51%
OM growth 5Y-10.85%
PM growth 3Y-20.58%
PM growth 5Y-12.29%
GM growth 3Y-0.21%
GM growth 5Y-0.29%
USNA Yearly Profit, Operating, Gross MarginsUSNA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so USNA is still creating some value.
  • Compared to 1 year ago, USNA has less shares outstanding
  • USNA has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for USNA is higher compared to a year ago.
USNA Yearly Shares OutstandingUSNA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
USNA Yearly Total Debt VS Total AssetsUSNA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • An Altman-Z score of 3.77 indicates that USNA is not in any danger for bankruptcy at the moment.
  • USNA has a better Altman-Z score (3.77) than 77.78% of its industry peers.
  • USNA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.77
ROIC/WACC0.47
WACC8.61%
USNA Yearly LT Debt VS Equity VS FCFUSNA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

  • A Current Ratio of 2.23 indicates that USNA has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.23, USNA is in line with its industry, outperforming 55.56% of the companies in the same industry.
  • USNA has a Quick Ratio of 1.46. This is a normal value and indicates that USNA is financially healthy and should not expect problems in meeting its short term obligations.
  • USNA has a Quick ratio of 1.46. This is comparable to the rest of the industry: USNA outperforms 58.33% of its industry peers.
Industry RankSector Rank
Current Ratio 2.23
Quick Ratio 1.46
USNA Yearly Current Assets VS Current LiabilitesUSNA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The earnings per share for USNA have decreased strongly by -30.74% in the last year.
  • Measured over the past years, USNA shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -10.07% on average per year.
  • The Revenue has been growing slightly by 5.88% in the past year.
  • The Revenue has been decreasing by -4.23% on average over the past years.
EPS 1Y (TTM)-30.74%
EPS 3Y-23.07%
EPS 5Y-10.07%
EPS Q2Q%-126.79%
Revenue 1Y (TTM)5.88%
Revenue growth 3Y-10.36%
Revenue growth 5Y-4.23%
Sales Q2Q%6.88%

3.2 Future

  • Based on estimates for the next years, USNA will show a small growth in Earnings Per Share. The EPS will grow by 3.30% on average per year.
  • Based on estimates for the next years, USNA will show a small growth in Revenue. The Revenue will grow by 6.09% on average per year.
EPS Next Y-31.74%
EPS Next 2Y-12.54%
EPS Next 3Y3.3%
EPS Next 5YN/A
Revenue Next Year8.86%
Revenue Next 2Y6.08%
Revenue Next 3Y6.09%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
USNA Yearly Revenue VS EstimatesUSNA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
USNA Yearly EPS VS EstimatesUSNA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 10.93, which indicates a very decent valuation of USNA.
  • USNA's Price/Earnings ratio is rather cheap when compared to the industry. USNA is cheaper than 83.33% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 28.03. USNA is valued rather cheaply when compared to this.
  • Based on the Price/Forward Earnings ratio of 10.77, the valuation of USNA can be described as reasonable.
  • Based on the Price/Forward Earnings ratio, USNA is valued a bit cheaper than the industry average as 77.78% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of USNA to the average of the S&P500 Index (27.97), we can say USNA is valued rather cheaply.
Industry RankSector Rank
PE 10.93
Fwd PE 10.77
USNA Price Earnings VS Forward Price EarningsUSNA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of USNA indicates a rather cheap valuation: USNA is cheaper than 94.44% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.85
USNA Per share dataUSNA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

  • The decent profitability rating of USNA may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-12.54%
EPS Next 3Y3.3%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for USNA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

USANA HEALTH SCIENCES INC

NYSE:USNA (2/10/2026, 8:04:00 PM)

After market: 21.43 0 (0%)

21.43

+0.23 (+1.08%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)10-09
Earnings (Next)02-17
Inst Owners61.98%
Inst Owner Change-3.42%
Ins Owners0.6%
Ins Owner Change0.04%
Market Cap391.74M
Revenue(TTM)912.67M
Net Income(TTM)16.99M
Analysts43.33
Price Target39.78 (85.63%)
Short Float %4.79%
Short Ratio3.48
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-48.47%
Min EPS beat(2)-131.29%
Max EPS beat(2)34.35%
EPS beat(4)3
Avg EPS beat(4)-16.63%
Min EPS beat(4)-131.29%
Max EPS beat(4)34.35%
EPS beat(8)6
Avg EPS beat(8)1.98%
EPS beat(12)9
Avg EPS beat(12)11.42%
EPS beat(16)9
Avg EPS beat(16)5.45%
Revenue beat(2)1
Avg Revenue beat(2)-1.82%
Min Revenue beat(2)-6.39%
Max Revenue beat(2)2.74%
Revenue beat(4)3
Avg Revenue beat(4)-0.68%
Min Revenue beat(4)-6.39%
Max Revenue beat(4)2.74%
Revenue beat(8)4
Avg Revenue beat(8)-1.55%
Revenue beat(12)7
Avg Revenue beat(12)-0.45%
Revenue beat(16)8
Avg Revenue beat(16)-1.17%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)2.5%
EPS NQ rev (3m)2.5%
EPS NY rev (1m)0.58%
EPS NY rev (3m)0.58%
Revenue NQ rev (1m)2.34%
Revenue NQ rev (3m)2.08%
Revenue NY rev (1m)0.56%
Revenue NY rev (3m)0.5%
Valuation
Industry RankSector Rank
PE 10.93
Fwd PE 10.77
P/S 0.43
P/FCF N/A
P/OCF 12.43
P/B 0.74
P/tB 1.59
EV/EBITDA 3.85
EPS(TTM)1.96
EY9.15%
EPS(NY)1.99
Fwd EY9.28%
FCF(TTM)-10.1
FCFYN/A
OCF(TTM)1.72
OCFY8.05%
SpS49.93
BVpS28.89
TBVpS13.44
PEG (NY)N/A
PEG (5Y)N/A
Graham Number35.69
Profitability
Industry RankSector Rank
ROA 2.34%
ROE 3.22%
ROCE 6.88%
ROIC 4.04%
ROICexc 5.3%
ROICexgc 13.62%
OM 4.58%
PM (TTM) 1.86%
GM 79.18%
FCFM N/A
ROA(3y)9.11%
ROA(5y)13.39%
ROE(3y)12.23%
ROE(5y)18.88%
ROIC(3y)10.32%
ROIC(5y)15.36%
ROICexc(3y)25.77%
ROICexc(5y)39.61%
ROICexgc(3y)41.63%
ROICexgc(5y)58.84%
ROCE(3y)17.59%
ROCE(5y)26.19%
ROICexgc growth 3Y-27.3%
ROICexgc growth 5Y-19.15%
ROICexc growth 3Y-45.52%
ROICexc growth 5Y-31.11%
OM growth 3Y-18.51%
OM growth 5Y-10.85%
PM growth 3Y-20.58%
PM growth 5Y-12.29%
GM growth 3Y-0.21%
GM growth 5Y-0.29%
F-Score5
Asset Turnover1.26
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 973.94%
Cap/Sales 23.69%
Interest Coverage 62.89
Cash Conversion 49.24%
Profit Quality N/A
Current Ratio 2.23
Quick Ratio 1.46
Altman-Z 3.77
F-Score5
WACC8.61%
ROIC/WACC0.47
Cap/Depr(3y)569.36%
Cap/Depr(5y)383.35%
Cap/Sales(3y)9.41%
Cap/Sales(5y)6.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-30.74%
EPS 3Y-23.07%
EPS 5Y-10.07%
EPS Q2Q%-126.79%
EPS Next Y-31.74%
EPS Next 2Y-12.54%
EPS Next 3Y3.3%
EPS Next 5YN/A
Revenue 1Y (TTM)5.88%
Revenue growth 3Y-10.36%
Revenue growth 5Y-4.23%
Sales Q2Q%6.88%
Revenue Next Year8.86%
Revenue Next 2Y6.08%
Revenue Next 3Y6.09%
Revenue Next 5YN/A
EBIT growth 1Y-49.2%
EBIT growth 3Y-26.96%
EBIT growth 5Y-14.62%
EBIT Next Year37.8%
EBIT Next 3Y22.6%
EBIT Next 5YN/A
FCF growth 1Y-347.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-62.96%
OCF growth 3Y-20.46%
OCF growth 5Y-13.6%

USANA HEALTH SCIENCES INC / USNA FAQ

What is the fundamental rating for USNA stock?

ChartMill assigns a fundamental rating of 5 / 10 to USNA.


Can you provide the valuation status for USANA HEALTH SCIENCES INC?

ChartMill assigns a valuation rating of 6 / 10 to USANA HEALTH SCIENCES INC (USNA). This can be considered as Fairly Valued.


Can you provide the profitability details for USANA HEALTH SCIENCES INC?

USANA HEALTH SCIENCES INC (USNA) has a profitability rating of 6 / 10.


What is the financial health of USANA HEALTH SCIENCES INC (USNA) stock?

The financial health rating of USANA HEALTH SCIENCES INC (USNA) is 7 / 10.


Can you provide the expected EPS growth for USNA stock?

The Earnings per Share (EPS) of USANA HEALTH SCIENCES INC (USNA) is expected to decline by -31.74% in the next year.